Document Detail


The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
MedLine Citation:
PMID:  9858557     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In Rat-1 fibroblasts nonmitogenic doses of lysophosphatidic acid (LPA) stimulate a transient activation of mitogen-activated protein kinase (MAPK), whereas mitogenic doses elicit a sustained response. This sustained phase of MAPK activation regulates cell fate decisions such as proliferation or differentiation, presumably by inducing a program of gene expression which is not observed in response to transient MAPK activation. We have examined the expression of members of the AP-1 transcription factor complex in response to stimulation with different doses of LPA. c-Fos, c-Jun, and JunB are induced rapidly in response to LPA stimulation, whereas Fra-1 and Fra-2 are induced after a significant lag. The expression of c-Fos is transient, whereas the expression of c-Jun, JunB, Fra-1, and Fra-2 is sustained. The early expression of c-Fos can be reconstituted with nonmitogenic doses of LPA, but the response is transient compared to that observed with mitogenic doses. In contrast, expression of Fra-1, Fra-2, and JunB and optimal expression of c-Jun are observed only with doses of LPA which induce sustained MAPK activation and DNA synthesis. LPA-stimulated expression of c-Fos, Fra-1, Fra-2, c-Jun, and JunB is inhibited by the MEK1 inhibitor PD098059, indicating that the Raf-MEK-MAPK cascade is required for their expression. In cells expressing a conditionally active form of Raf-1 (DeltaRaf-1:ER), we observed that selective, sustained activation of Raf-MEK-MAPK was sufficient to induce expression of Fra-1, Fra-2, and JunB but, interestingly, induced little or no c-Fos or c-Jun. The induction of c-Fos observed in response to LPA was strongly inhibited by buffering the intracellular [Ca2+]. Moreover, although Raf activation or calcium ionophores induced little c-Fos expression, we observed a synergistic induction in response to the combination of DeltaRaf-1:ER and ionomycin. These results suggest that kinetically distinct phases of MAPK activation serve to regulate the expression of distinct AP-1 components such that sustained MAPK activation is required for the induced expression of Fra-1, Fra-2, c-Jun, and JunB. However, in contrast to the case for Fra-1, Fra-2, and JunB, activation of the MAPK cascade alone is not sufficient to induce c-Fos expression, which rather requires cooperation with other signals such as Ca2+ mobilization. Finally, the identification of the Fra-1, Fra-2, c-Jun, and JunB genes as genes which are selectively regulated by sustained MAPK activation or in response to activated Raf suggests that they are candidates to mediate certain of the effects of Ras proteins in oncogenic transformation.
Authors:
S J Cook; N Aziz; M McMahon
Related Documents :
7693017 - The conjunctive stimuli that cause long-term desensitization also predominantly induce ...
8345107 - Jun, fos, krox, and creb transcription factor proteins in the rat cortex: basal express...
10095097 - Inducible transcription factor expression in a cell culture model of apoptosis.
23280137 - The tnfα-induced mir-18a activates rheumatoid arthritis synovial fibroblasts through a ...
9834197 - In vivo analysis using variants of zebrafish bmpr-ia: range of action and involvement o...
18259197 - Biology of hypoxia-inducible factor-2alpha in development and disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Molecular and cellular biology     Volume:  19     ISSN:  0270-7306     ISO Abbreviation:  Mol. Cell. Biol.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-02-10     Completed Date:  1999-02-10     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8109087     Medline TA:  Mol Cell Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  330-41     Citation Subset:  IM    
Affiliation:
ONYX Pharmaceuticals, Richmond, California 94806, USA. simon.cook@bbsrc.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3T3 Cells
Animals
Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
Cell Cycle
Cell Line
DNA-Binding Proteins / biosynthesis
Enzyme Activation
Enzyme Inhibitors / pharmacology
Flavonoids / pharmacology
Fos-Related Antigen-2
G1 Phase
Gene Expression Regulation / drug effects
Kinetics
Lysophospholipids / pharmacology
Mice
Proto-Oncogene Proteins c-fos / biosynthesis,  genetics*
Proto-Oncogene Proteins c-jun / genetics*
Proto-Oncogene Proteins c-raf / genetics
Rats
Transcription Factor AP-1 / genetics*
Transcription Factors / biosynthesis
Chemical
Reg. No./Substance:
0/2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 0/DNA-Binding Proteins; 0/Enzyme Inhibitors; 0/Flavonoids; 0/Fos-Related Antigen-2; 0/Fosl2 protein, mouse; 0/Fosl2 protein, rat; 0/Lysophospholipids; 0/Proto-Oncogene Proteins c-fos; 0/Proto-Oncogene Proteins c-jun; 0/Transcription Factor AP-1; 0/Transcription Factors; 0/fos-related antigen 1; EC 2.7.11.1/Proto-Oncogene Proteins c-raf; EC 2.7.11.17/Calcium-Calmodulin-Dependent Protein Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinas...
Next Document:  Functional domains of the Rsp5 ubiquitin-protein ligase.